Squadron reports 8.25M-share (8.5%) stake in Palisade Bio (PALI)
Schedule 13G filed for Palisade Bio, Inc. (PALI) discloses that several related reporting persons tied to Squadron Capital hold significant passive stakes in the company.
Rhea-AI Filing Summary
Schedule 13G filed for Palisade Bio, Inc. (PALI) discloses that several related reporting persons tied to Squadron Capital hold significant passive stakes in the company. The filing shows Squadron Master Fund LP beneficially owns 7,308,580 shares (representing 7.6% of the outstanding common stock) and Squadron Capital Management LLC and two partners, Matthew Sesterhenn and William Blank, each report ownership of 8,250,000 shares (each representing 8.5%). All reported holdings are shared voting and dispositive power; no reporting person claims sole voting or sole dispositive power. The ownership percentages are calculated from a stated base of 96,645,431 shares outstanding as of 10/01/2025. The filing includes the standard Rule 13d-4 disclaimer that the advisers and partners disclaim beneficial ownership.
Positive
- Disclosure of material stakes: Squadron entities report holdings above the 5% SEC threshold (7,308,580 and 8,250,000 shares).
- Filed as Schedule 13G, which indicates the positions are reported as passive under current statements.
Negative
- No sole voting or dispositive power reported, which limits direct control despite size of holdings.
- Rule 13d-4 disclaimer by the adviser and partners creates ambiguity about ultimate beneficial ownership and future intent.
Insights
Large passive stakes disclosed: two related entities report up to 8.5%.
The data shows 8,250,000 shares tied to Squadron Capital and each named partner, and 7,308,580 shares held by Squadron Master Fund LP, representing meaningful minority positions against a 96,645,431-share base. These positions exceed the common 5% disclosure threshold and are reported under Schedule 13G, which typically signals passive intent rather than an active control campaign.
The primary dependencies are the reporting persons' disclaimers under Rule 13d-4 and the classification as passive; watch for any future amendment converting to Schedule 13D or additional filings within the next months that would indicate a shift in intent.
Shared voting and dispositive power noted; no sole control claimed.
All reporting persons list 0 sole voting and dispositive power and report shared power for the stated share counts. The filing's certification asserts the securities were not acquired to change or influence control, and the Rule 13d-4 disclaimer preserves that stance. This limits immediate governance impact but still gives the group a blocking minority range on certain matters.
Investors should track any engagement disclosures or proxy-related communications over the typical proxy season and any amendments within 90 days that would change classification from passive to active.
FAQ
What stake did Squadron Capital report in Palisade Bio (PALI)?
Are these holdings reported as passive or active for PALI?
Does the filing indicate any intent to change or influence control of PALI?
AI-generated analysis. How Rhea-AI works. Not financial advice.